Top

Clinical Orthopaedics and Related Research®

Published in:

01-08-2011 | Symposium: Bone Quality: From Bench to Bedside

Infrared Assessment of Bone Quality: A Review

Authors: Eleftherios P. Paschalis, PhD, Richard Mendelsohn, PhD, Adele L. Boskey, PhD

Published in: Clinical Orthopaedics and Related Research® | Issue 8/2011

Abstract

Background

Bone strength depends on both bone quantity and quality. The former is routinely estimated in clinical settings through bone mineral density measurements but not the latter. Bone quality encompasses the structural and material properties of bone. Although its importance is appreciated, its contribution in determining bone strength has been difficult to precisely quantify partly because it is multifactorial and requires investigation of all bone hierarchical levels. Fourier transform infrared spectroscopy provides one way to explore these levels.

Questions/purposes

The purposes of our review were to (1) provide a brief overview of Fourier transform infrared spectroscopy as a way to establish bone quality, (2) review the major bone material parameters determined from Fourier transform infrared spectroscopy, and (3) review the role of Fourier transform infrared microspectroscopic analysis in establishing bone quality.

Methods

We used the ISI Web of Knowledge database initially to identify articles containing the Boolean term “infrared” AND “bone.” We then focused on articles on infrared spectroscopy in bone-related journals.

Results

Infrared spectroscopy provides information on bone material properties. Their microspectroscopic versions allow one to establish these properties as a function of anatomic location, mineralization extent, and bone metabolic activity. It provides answers pertaining to the contribution of mineral to matrix ratio, mineral maturity, mineral carbonate substitution, and collagen crosslinks to bone strength. Alterations of bone material properties have been identified in disease (especially osteoporosis) not attainable by other techniques.

Conclusions

Infrared spectroscopic analysis is a powerful tool for establishing the important material properties contributing to bone strength and thus has helped better understand changes in fragile bone.

Blouin S, Thaler HW, Korninger C, Schmid R, Hofstaetter JG, Zoehrer R, Phipps R, Klaushofer K, Roschger P, Paschalis EP. Bone matrix quality and plasma homocysteine levels. Bone. 2009;44:959–964.PubMedCrossRef

Blumenthal NC, Betts F, Posner AS. Effect of carbonate and biological macromolecules on formation and properties of hydroxyapatite. Calcif Tissue Res. 1975;18:81–90.PubMedCrossRef

Bohic S, Heymann D, Pouezat JA, Gauthier O, Daculsi G. Transmission FT-IR microspectroscopy of mineral phases in calcified tissues. C R Acad Sci III. 1998;321:865–876.PubMed

Boskey AL, DiCarlo E, Paschalis E, West P, Mendelsohn R. Comparison of mineral quality and quantity in iliac crest biopsies from high- and low-turnover osteoporosis: an FT-IR microspectroscopic investigation. Osteoporos Int. 2005;16:2031–2038.PubMedCrossRef

Boskey AL, Mendelsohn R. Infrared spectroscopic characterization of mineralized tissues. Vib Spectrosc. 2005;38:107–114.PubMedCrossRef

Boskey AL, Pleshko N, Doty SB, Mendelsohn R. Applications of FT-IR microscopy to the study of mineralization in bone and cartilage. Cell Materials. 1992;2:209–220.

Boskey AL, Spevak L, Weinstein RS. Spectroscopic markers of bone quality in alendronate-treated postmenopausal women. Osteoporos Int. 2009;20:793–800.PubMedCrossRef

Boyce TM, Bloebaum RD. Cortical aging differences and fracture implications for the human femoral neck. Bone. 1993;14:769–778.PubMedCrossRef

Bullough P. The tissue diagnosis of metabolic bone disease. Orthop Clin North Am. 1990;21:65–79.PubMed

10.

Bullough P. Atlas of Orthopaedic Pathology. New York, NY: Gower Medical Publishing; 1992.

11.

Burr DB, Miller L, Grynpas M, Li J, Boyde A, Mashiba T, Hirano T, Johnston CC. Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs. Bone. 2003;33:960–969.PubMedCrossRef

12.

Camacho NP, Rinnerthaler S, Paschalis EP, Mendelsohn R, Boskey AL, Fratzl P. Complementary information on bone ultrastructure from scanning small angle x-ray scattering and Fourier-transform infrared microspectroscopy. Bone. 1999;25:287–293.PubMedCrossRef

13.

Childs LM, Paschalis EP, Xing L, Dougall WC, Anderson D, Boskey AL, Puzas JE, Rosier RN, O’Keefe RJ, Boyce BF, Schwarz EM. In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis. J Bone Miner Res. 2002;17:192–199.PubMedCrossRef

14.

Cummings SR. Are patients with hip fractures more osteoporotic? Review of the evidence. Am J Med. 1985;78:487–494.PubMedCrossRef

15.

Dong A, Huang P, Caughey WS. Protein secondary structures in water from second-derivative amide I infrared spectra. Biochemistry. 1990;29:3303–3308.PubMedCrossRef

16.

Dumas P, Jamin N, Teillaud JL, Miller LM, Beccard B. Imaging capabilities of synchrotron infrared microspectroscopy. Faraday Discuss. 2004;126:289–302; discussion 303–311.

17.

Durchschlag E, Paschalis EP, Zoehrer R, Roschger P, Fratzl P, Recker R, Phipps R, Klaushofer K. Bone material properties in trabecular bone from human iliac crest biopsies after 3- and 5-year treatment with risedronate. J Bone Miner Res. 2006;21:1581–1590.PubMedCrossRef

18.

Einhorn TA. The bone organ system: form and function. In: Marcus R, Feldman D, Kelsey J, eds. Osteoporosis. New York, NY: Academic Press Inc; 1996.

19.

Federman S, Miller LM, Sagi I. Following matrix metalloproteinases activity near the cell boundary by infrared micro-spectroscopy. Matrix Biol. 2002;21:567–577.PubMedCrossRef

20.

Fratzl P, Gupta HS, Paschalis EP, Roschger P. Structure and mechanical quality of the collagen-mineral nano-composite in bone. J Mater Chem. 2004;14:2115–2123.CrossRef

21.

Fratzl P, Roschger P, Eschberger J, Abendroth B, Klaushofer K. Abnormal bone mineralization after fluoride treatment in osteoporosis: a small-angle x-ray-scattering study. J Bone Miner Res. 1994;9:1541–1549.PubMedCrossRef

22.

Fratzl P, Roschger P, Fratzl-Zelman N, Paschalis EP, Phipps R, Klaushofer K. Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume. Calcif Tissue Int. 2007;81:73–80.PubMedCrossRef

23.

Fratzl P, Schreiber S, Roschger P, Lafage MH, Rodan G, Klaushofer K. Effects of sodium fluoride and alendronate on the bone mineral in minipigs: a small-angle x-ray scattering and backscattered electron imaging study. J Bone Miner Res. 1996;11:248–253.PubMedCrossRef

24.

Gadaleta SJ, Paschalis EP, Betts F, Mendelsohn R, Boskey AL. Fourier transform infrared spectroscopy of the solution-mediated conversion of amorphous calcium phosphate to hydroxyapatite: new correlations between x-ray diffraction and infrared data. Calcif Tissue Int. 1996;58:9–16.PubMedCrossRef

25.

George A, Veis A. FTIRS in H₂O demonstrates that collagen monomers undergo a conformational transition prior to thermal self-assembly in vitro. Biochemistry. 1991;30:2372–2377.PubMedCrossRef

26.

Gourion-Arsiquaud S, Allen MR, Burr DB, Vashishth D, Tang SY, Boskey AL. Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity. Bone. 2010;46:666–672.PubMedCrossRef

27.

Gourion-Arsiquaud S, Faibish D, Myers E, Spevak L, Compston J, Hodsman A, Shane E, Recker RR, Boskey ER, Boskey AL. Use of FTIR spectroscopic imaging to identify parameters associated with fragility fracture. J Bone Miner Res. 2009;24:1565–1571.PubMedCrossRef

28.

Gourion-Arsiquaud S, West PA, Boskey AL. Fourier transform-infrared microspectroscopy and microscopic imaging. Methods Mol Biol. 2008;455:293–303.PubMedCrossRef

29.

Henneman ZJ, Nancollas GH, Ebetino FH, Russell RG, Phipps RJ. Bisphosphonate binding affinity as assessed by inhibition of carbonated apatite dissolution in vitro. J Biomed Mater Res A. 2008;85:993–1000.PubMed

30.

Huang RY, Miller LM, Carlson CS, Chance MR. Characterization of bone mineral composition in the proximal tibia of cynomolgus monkeys: effect of ovariectomy and nandrolone decanoate treatment. Bone. 2002;30:492–497.PubMedCrossRef

31.

Huang RY, Miller LM, Carlson CS, Chance MR. In situ chemistry of osteoporosis revealed by synchrotron infrared microspectroscopy. Bone. 2003;33:514–521.PubMedCrossRef

32.

Hui S, Slemenda CW, Johnston CC. Age and bone mass as predictors of fracture in a prospective study. J Clin Invest. 1988;81:1804–1809.PubMedCrossRef

33.

Jepsen KJ, Schaffler MB. Bone mass does not adequately predict variations in bone fragility: a genetic approach. Trans Orthop Res Soc. 2001;26:114.

34.

Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9:1137–1142.PubMedCrossRef

35.

Kann P, Graeben S, Beyer J. Age-dependence of bone material quality shown by the measurement of frequency of resonance in the ulna. Calcif Tissue Int. 1994;54:96–100.PubMedCrossRef

36.

Kennedy DF, Crisma M, Toniolo C, Chapman D. Studies of peptides forming 3(10)- and alpha-helices and beta-bend ribbon structures in organic solution and in model biomembranes by Fourier transform infrared spectroscopy. Biochemistry. 1991;30:6541–6548.PubMedCrossRef

37.

Lazarev YA, Grishkovsky BA, Khromova TB. Amide I band spectrum and structure of collagen and related polypeptides. Biopolymers. 1985;24:1449–1478.PubMedCrossRef

38.

Lazarev YA, Grishkovsky BA, Khromova TB, Lazareva AV, Grechishko VS. Bound water in the collagen-like triple-helical structure. Biopolymers. 1992;32:189–195.PubMedCrossRef

39.

Lazarev YA, Lazareva AV, Shibnev A, Esipova NG. Infrared-spectra and structure of synthetic polytripeptides. Biopolymers. 1978;17:1197–1214.CrossRef

40.

Li C, Paris O, Siegel S, Roschger P, Paschalis E, Klaushofer K, Fratzl P. Strontium is incorporated into mineral crystals only in newly formed bone during strontium ranelate treatment. J Bone Miner Res. 2010;25:968–975.PubMed

41.

Manolagas SC. Corticosteroids and fractures: a close encounter of the third cell kind. J Bone Miner Res. 2000;15:1001–1005.PubMedCrossRef

42.

Marcott C, Reeder RC, Paschalis EP, Tatakis DN, Boskey AL, Mendelsohn R. Infrared microspectroscopic imaging of biomineralized tissues using a mercury-cadmium-telluride focal-plane array detector. Cell Mol Biol (Noisy-le-grand). 1998;44:109–115.

43.

Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312:1254–1259.PubMed

44.

McCabe F, Zhou LJ, Steele CR, Marcus R. Noninvasive assessment of ulnar bending stiffness in women. J Bone Miner Res. 1991;6:53–59.PubMedCrossRef

45.

McCreadie RB, Goldstein AS. Biomechanics of fracture: is bone mineral density sufficient to assess risk? J Bone Miner Res. 2000;15:2305–2308.PubMedCrossRef

46.

Mendelsohn R, Hassankhani A, DiCarlo E, Boskey A. FT-IR microscopy of endochondral ossification at 20 mu spatial resolution. Calcif Tissue Int. 1989;44:20–24.PubMedCrossRef

47.

Miller LM, Carlson CS, Carr GL, Chance MR. A method for examining the chemical basis for bone disease: synchrotron infrared microspectroscopy. Cell Mol Biol (Noisy-le-grand). 1998;44:117–127.

48.

Miller LM, Vairavamurthy V, Chance MR, Mendelsohn R, Paschalis EP, Betts F, Boskey AL. In situ analysis of mineral content and crystallinity in bone using infrared micro-spectroscopy of the nu(4) PO(4)(3−) vibration. Biochim Biophys Acta. 2001;1527:11–19.PubMed

49.

Monier-Faugere MC, Geng Z, Paschalis EP, Qi Q, Arnala I, Bauss F, Boskey AL, Malluche HH. Intermittent and continuous administration of the bisphosphonate ibandronate in ovariohysterectomized beagle dogs: effects on bone morphometry and mineral properties. J Bone Miner Res. 1999;14:1768–1778.PubMedCrossRef

50.

Mosekilde L, Mosekilde L, Danielsen CC. Biomechanical competence of vertebral trabecular bone in relation to ash density and age in normal individuals. Bone. 1987;8:79–85.PubMedCrossRef

51.

Nancollas GH, Tang R, Phipps RJ, Henneman Z, Gulde S, Wu W, Mangood A, Russell RG, Ebetino FH. Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. Bone. 2006;38:617–627.PubMedCrossRef

52.

Ouyang H, Sherman PJ, Paschalis EP, Boskey AL, Mendelsohn R. Fourier transform infrared microscopic imaging: effects of estrogen and estrogen deficiency on fracture healing in rat femurs. Appl Spectrosc. 2004;58:1–9.PubMedCrossRef

53.

Parfitt AM. Bone remodeling and bone loss: understanding the pathophysiology of osteoporosis. Clin Obs Gynecol. 1987;30:789–811.CrossRef

54.

Paschalis EP. Fourier transform infrared analysis and bone. Osteoporos Int. 2009;20:1043–1047.PubMedCrossRef

55.

Paschalis EP, Boskey AL, Kassem M, Eriksen EF. Effect of hormone replacement therapy on bone quality in early postmenopausal women. J Bone Miner Res. 2003;18:955–959.PubMedCrossRef

56.

Paschalis EP, Burr DB, Mendelsohn R, Hock JM, Boskey AL. Bone mineral and collagen quality in humeri of ovariectomized cynomolgus monkeys given rhPTH(1–34) for 18 months. J Bone Miner Res. 2003;18:769–775.PubMedCrossRef

57.

Paschalis EP, DiCarlo E, Betts F, Sherman P, Mendelsohn R, Boskey AL. FTIR microspectroscopic analysis of human osteonal bone. Calcif Tissue Int. 1996;59:480–487.PubMed

58.

Paschalis EP, Glass EV, Donley DW, Eriksen EF. Bone mineral and collagen quality in iliac crest biopsies of patients given teriparatide: new results from the fracture prevention trial. J Clin Endocrinol Metab. 2005;90:4644–4649.PubMedCrossRef

59.

Paschalis EP, Recker R, DiCarlo E, Doty SB, Atti E, Boskey AL. Distribution of collagen cross-links in normal human trabecular bone. J Bone Miner Res. 2003;18:1942–1946.PubMedCrossRef

60.

Paschalis EP, Shane E, Lyritis G, Skarantavos G, Mendelsohn R, Boskey AL. Bone fragility and collagen cross-links. J Bone Miner Res. 2004;19:2000–2004.PubMedCrossRef

61.

Paschalis EP, Verdelis K, Doty SB, Boskey AL, Mendelsohn R, Yamauchi M. Spectroscopic characterization of collagen cross-links in bone. J Bone Miner Res. 2001;16:1821–1828.PubMedCrossRef

62.

Pleiner-Duxneuner J, Zwettler E, Paschalis E, Roschger P, Nell-Duxneuner V, Klaushofer K. Treatment of osteoporosis with parathyroid hormone and teriparatide. Calcif Tissue Int. 2009;84:159–170.PubMedCrossRef

63.

Posner AS. Bone mineral on the molecular level. Fed Proc. 1973;32:1933–1937.PubMed

64.

Raisz LG, Kream BE. Regulation of bone formation. N Engl J Med. 1983;309:29–35.PubMedCrossRef

65.

Rey C, Collins B, Goehl T, Dickson IR, Glimcher MJ. The carbonate environment in bone mineral: a resolution-enhanced Fourier transform infrared spectroscopy study. Calcif Tissue Int. 1989;45:157–164.PubMedCrossRef

66.

Rey C, Miquel JL, Facchini L, Legrand AP, Glimcher MJ. Hydroxyl groups in bone mineral. Bone. 1995;16:583–586.PubMedCrossRef

67.

Rey C, Renugopalakrishnan V, Collins B, Glimcher MJ. Fourier transform infrared spectroscopic study of the carbonate ions in bone mineral during aging. Calcif Tissue Int. 1991;49:251–258.PubMedCrossRef

68.

Rey C, Shimizu M, Collins B, Glimcher MJ. Resolution-enhanced Fourier transform infrared spectroscopy study of the environment of phosphate ion in the early deposits of a solid phase of calcium phosphate in bone and enamel and their evolution with age. 2. Investigations in the nu3PO4 domain. Calcif Tissue Int. 1991;49:383–388.PubMedCrossRef

69.

Rinnerthaler S, Roschger P, Jakob HF, Nader A, Klaushofer K, Fratzl P. Scanning small angle x-ray scattering analysis of human bone sections. Calcif Tissue Int. 1999;64:422–429.PubMedCrossRef

70.

Roschger P, Fratzl P, Klaushofer K, Rodan G. Mineralization of cancellous bone after alendronate and sodium fluoride treatment: a quantitative backscattered electron imaging study on minipig ribs. Bone. 1997;20:393–397.PubMedCrossRef

71.

Roschger P, Manjubala I, Zoeger N, Meirer F, Simon R, Li C, Fratzl-Zelman N, Misof B, Paschalis E, Streli C, Fratzl P, Klaushofer K. Bone material quality in transiliac bone biopsies of postmenopausal osteoporotic women after 3 years strontium ranelate treatment. J Bone Miner Res. 2010;25:891–900.PubMedCrossRef

72.

Roschger P, Paschalis EP, Fratzl P, Klaushofer K. Bone mineralization density distribution in health and disease. Bone. 2008;42:456–466.PubMedCrossRef

73.

Termine JD, Lundy DR. Hydroxide and carbonate in rat bone mineral and its synthetic analogues. Calcif Tissue Res. 1973;13:73–82.PubMedCrossRef

74.

Termine JD, Posner AS. Infrared analysis of rat bone: age dependency of amorphous and crystalline mineral fractions. Science. 1966;153:1523–1525.PubMedCrossRef

75.

Thaler R, Spitzer S, Rumpler M, Fratzl-Zelman N, Klaushofer K, Paschalis EP, Varga F. Differential effects of homocysteine and beta aminopropionitrile on preosteoblastic MC3T3-E1 cells. Bone. 2010;46:703–709.PubMedCrossRef

76.

Weis MA, Wilkin DJ, Kim HJ, Wilcox WR, Lachman RS, Rimoin DL, Cohn DH, Eyre DR. Structurally abnormal type II collagen in a severe form of Kniest dysplasia caused by an exon 24 skipping mutation. J Biol Chem. 1998;273:4761–4768.PubMedCrossRef

Title: Infrared Assessment of Bone Quality: A Review
Authors: Eleftherios P. Paschalis, PhD
Richard Mendelsohn, PhD
Adele L. Boskey, PhD
Publication date: 01-08-2011
Publisher: Springer-Verlag
Published in: Clinical Orthopaedics and Related Research® / Issue 8/2011
Print ISSN: 0009-921X
Electronic ISSN: 1528-1132
DOI: https://doi.org/10.1007/s11999-010-1751-4

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Infrared Assessment of Bone Quality: A Review

Abstract

Background

Questions/purposes

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Questions/purposes

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2011

Emerging Ideas: Can Erythromycin Reduce the Risk of Aseptic Loosening?

Surgical Treatment Options in Patients With Impaired Bone Quality

High-resolution Computed Tomography for Clinical Imaging of Bone Microarchitecture

Is Noncontact ACL Injury Associated with the Posterior Tibial and Meniscal Slope?

Functional Interactions Among Morphologic and Tissue Quality Traits Define Bone Quality

Europium Stearate Additives Delay Oxidation of UHMWPE for Orthopaedic Applications: A Pilot Study